XNAS · BMRA
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
BIOMERICA INC

BIOMERICA INC

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$1.91
Card
Relationship Map

Follow $BMRA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BMRA by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
BMRA
BIOMERICA INC
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

51/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BMRA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BMRA catalysts
About BIOMERICA INC
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
1978
Employees
50
Country
US

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.91
Last session
Day high
$1.91
Last session
Day low
$1.91
Last session
Previous close
$1.91
52W high
$3.20
-40.31% from high
52W low
$1.49
25% of range
Market cap
$8.8M
Beta
0.51
Shares out
4.6M
Avg volume
143.9K
VWAP
$1.91
Last session
Price history computed in-house
1W
-14.55%
1M
-18.38%
3M
+13.02%
1Y
-33.68%
YTD
-24.21%
SMA 50 $2.00 · below
SMA 200 $2.12 · below
52W position 25%

BMRA overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading BMRA Form 4 filings
Public disclosures

Congress activity in BMRA

No receipt-qualified filings found.

Federal contracts

BMRA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BMRA in this window.
Lobbying spend

BMRA lobbying filings, year to date.

Registered lobbying filings matched to BIOMERICA INC.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BMRA in this window.
Loading news for BMRA
Analyst ratings
Sovereign unlock shows live analyst consensus for BMRA.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.